Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction

Circulation

Volumn 115, Issue 18, 2007, Pages

  Zarich, Stuart W ^a   Nesto, Richard W ^b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ACUTE HEART INFARCTION; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; CARDIOVASCULAR EFFECT; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE PERFUSION; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; LEFT ANTERIOR DESCENDING CORONARY ARTERY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ST SEGMENT ELEVATION;

ACUTE DISEASE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD GLUCOSE; CLINICAL TRIALS; EMERGENCY MEDICAL SERVICES; FASTING; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE INTOLERANCE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; POTASSIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; STENTS; STRESS;

EID: 34248228719     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.105.535732     Document Type: Review

References (23)

1. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002;40:1748-1754.
2. Norhammar A, Tenerz A, Nilsson G, Hansten A, efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140-2144.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
4. Malmberg K, Norhammar A, Wedel H, Ryden L. Glycometabolic state at admission: Important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation. 1999;99:2626-2632.
5. Stranders I, Diamant M, van Gelder R, Spruijt H, Twisk JWR, Heine RJ, Visser FC. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med. 2004;164:982-988.
6. Zeller M, Steg P, Ravisy J, Laurent Y, Janin-Manificat L, L'Huillier I, Beer J, Oudot A, Rioufol G, Makki H, Farnier M, Rochette L, Verges, Cottin Y. Prevalence and impact of metabolic syndrome on hospital outcomes in acute myocardial infarction. Arch Intern Med. 2005;165:1192-1198.
7. Suleiman M, Hammerman H, Boulos M, Kapeliovich M, Suleiman A, Agmon Y, Markiewicz W, Aronson D. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction. Circulation. 2005;111:754-760.
8. Goyal A, Mahaffey K, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GBF, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. Prognostic significance of the change in glucose level in the first 24h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289-1297.
9. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 1999;34:146-154.
10. Monnier L, Mas E, Ginet C, Michel F, Willon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295:1681-1687.
11. Timmer J, Ottervanger J, de Boer M, Dambrink JE, Hoorntje JCA, Gosselink ATM, Suryapranata H, Zijlstra F, Van't Hof AWJ, for the Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;45:999-1002.
12. Prasad A, Stone G, Stuckey T, Costantini CO, Zimetbaum PJ, McLaughlin M, Mehran R, Garcia E, Tcheng JE, Cox DA, Grines CL, Lansky AJ, Gersh BJ. Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction. J Am Coll Cardiol. 45:508-514.
13. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1-7.
14. Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, Shulman GI, Sinusas AJ. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415-422.
15. Sodi-Pallares D, Testelli MR, Fishleder BL, Bisteni A, Medrano GA, Friedland C, DeMicheli A. Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction: a preliminary clinical report. Am J Cardiol. 1962;9:166-181.
16. Mehta SR, Yusuf S, Diaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L, for the CEATE-ECLA Trial Group Investigators. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA Randomized Controlled Trial. JAMA. 2005;293:437-444.
17. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461.
18. Srinivasan M, Herrero P, McGill J, Bennik J, Heere B, Lesniak D, Davila-Roman VG, Groopler RJ. The effects of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus. J Am Coll Cardiol. 2005;46:42-48.
19. Scogamiglio R, Negut C, Vigili De Kreutzenberg S, Tiengo A, Avogaro A. Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation. 2005;112:179-184.
20. Wang P, Lloyd S, Chatham J. Impact of high glucose/high insulin and dichloroacetate treatment on carbohydrate oxidation and functional recovery after low-flow ischemia and reperfusion in the isolated perfused rat heart. Circulation. 2005;111:2066-2072.
21. Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distinct dream or near reality? Heart. 2000;83:381-387.
22. Chaudhuri A, Janicke D, Wilson MF, Tripathy D, Garg R, Bandyopadhyay A, Calieri J, Hoffmeyer D, Tufail S, Ghanim H, Aljada A, Dandona P. Anti-inflammatory and pro-fibrinolytic effect of insulin in acute ST-elevation myocardial infarction. Circulation. 2004;109:849-854.
23. Inzucchi S. Management of hyperglycemia in the hospital setting. N Engl J Med. 2006;155:1903-1911.